Avestar Capital LLC Has $786,000 Stake in Synopsys, Inc. (NASDAQ:SNPS)

Avestar Capital LLC cut its holdings in shares of Synopsys, Inc. (NASDAQ:SNPS) by 1.3% during the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 1,552 shares of the semiconductor company’s stock after selling 20 shares during the quarter. Avestar Capital LLC’s holdings in Synopsys were worth $786,000 at the end of the most recent reporting period.

A number of other large investors also recently modified their holdings of SNPS. Andina Capital Management LLC increased its position in shares of Synopsys by 2.8% in the second quarter. Andina Capital Management LLC now owns 664 shares of the semiconductor company’s stock valued at $395,000 after acquiring an additional 18 shares during the last quarter. Cascade Financial Partners LLC increased its position in shares of Synopsys by 4.9% during the 2nd quarter. Cascade Financial Partners LLC now owns 389 shares of the semiconductor company’s stock worth $232,000 after purchasing an additional 18 shares during the last quarter. Hazlett Burt & Watson Inc. raised its stake in shares of Synopsys by 40.0% during the 3rd quarter. Hazlett Burt & Watson Inc. now owns 70 shares of the semiconductor company’s stock worth $35,000 after purchasing an additional 20 shares in the last quarter. Hilltop National Bank boosted its holdings in shares of Synopsys by 6.0% in the 2nd quarter. Hilltop National Bank now owns 370 shares of the semiconductor company’s stock valued at $220,000 after buying an additional 21 shares during the last quarter. Finally, Green Alpha Advisors LLC grew its stake in shares of Synopsys by 1.7% in the third quarter. Green Alpha Advisors LLC now owns 1,294 shares of the semiconductor company’s stock valued at $655,000 after buying an additional 22 shares in the last quarter. 85.47% of the stock is currently owned by institutional investors and hedge funds.

Analysts Set New Price Targets

A number of analysts have commented on the stock. JPMorgan Chase & Co. increased their price target on shares of Synopsys from $655.00 to $685.00 and gave the company an “overweight” rating in a research note on Thursday, August 22nd. Robert W. Baird upped their price objective on Synopsys from $661.00 to $663.00 and gave the company an “outperform” rating in a research note on Thursday, August 22nd. Berenberg Bank assumed coverage on Synopsys in a research report on Tuesday, October 15th. They issued a “buy” rating and a $660.00 price objective for the company. Wells Fargo & Company started coverage on Synopsys in a research note on Friday, November 22nd. They issued an “equal weight” rating and a $570.00 price target on the stock. Finally, Mizuho started coverage on shares of Synopsys in a research report on Tuesday, October 22nd. They set an “outperform” rating and a $650.00 price objective for the company. One investment analyst has rated the stock with a hold rating and eleven have assigned a buy rating to the company’s stock. According to MarketBeat.com, Synopsys has a consensus rating of “Moderate Buy” and an average price target of $644.36.

Synopsys Stock Performance

Shares of Synopsys stock opened at $553.95 on Wednesday. The firm has a 50-day moving average of $523.08 and a 200-day moving average of $545.69. Synopsys, Inc. has a 52-week low of $457.52 and a 52-week high of $629.38. The stock has a market cap of $85.09 billion, a PE ratio of 57.46, a PEG ratio of 3.43 and a beta of 1.08.

Synopsys Company Profile

Synopsys, Inc provides electronic design automation software products used to design and test integrated circuits. It operates in three segments: Design Automation, Design IP, and Software Integrity. The company offers Digital and Custom IC Design solution that provides digital design implementation solutions; Verification solution that offers virtual prototyping, static and formal verification, simulation, emulation, field programmable gate array (FPGA)-based prototyping, and debug solutions; and FPGA design products that are programmed to perform specific functions.